Detalhe da pesquisa
1.
Incidence, risk factors, and management of bleeding in patients receiving anticoagulants for the treatment of cancer-associated thrombosis.
Support Care Cancer
; 30(4): 2919-2931, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34617159
2.
Results from the LIDO anemia survey: adherence to EORTC guidelines in cancer patients in France.
Support Care Cancer
; 24(8): 3347-51, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-26980330
3.
Prevalence of renal abnormalities in chronic HBV infection: the HARPE study.
Liver Int
; 35(1): 148-55, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24502506
4.
Anticancer Drugs in End-Stage Kidney Disease Patients.
Semin Dial
; 28(4): 413-6, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25864698
5.
Acute renal failure associated with the new BRAF inhibitor vemurafenib: a case series of 8 patients.
Cancer
; 120(14): 2158-63, 2014 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24737576
6.
Renal insufficiency, mortality, and drug management in heart transplant. Results of the CARIN study.
Transpl Int
; 27(9): 931-8, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24853579
7.
How to manage the dose of drugs in cancer patients with acute kidney injury, practical recommendations.
Int J Clin Pharm
; 46(1): 210-213, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37884841
8.
Administration of intravenous iron complexes on implantable central venous access port in cancer patients in France: the FERPAC survey.
Support Care Cancer
; 21(10): 2743-8, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23715817
9.
[How to adjust the dose of drugs in chronic kidney disease?]. / Comment adapter la dose des médicaments dans la maladie rénale chronique?
Rev Prat
; 62(3): 309-11, 314-5, 2012 Mar.
Artigo
em Francês
| MEDLINE | ID: mdl-22514978
10.
Inappropriate drug use and mortality in community-dwelling elderly with impaired kidney function--the Three-City population-based study.
Nephrol Dial Transplant
; 26(9): 2852-9, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21292816
11.
[Renal toxicity of anticancer drugs]. / Toxicité rénale des anticancéreux.
Nephrol Ther
; 17(7): 553-563, 2021 Dec.
Artigo
em Francês
| MEDLINE | ID: mdl-34802974
12.
Prevalence of renal insufficiency in breast cancer patients and related pharmacological issues.
Breast Cancer Res Treat
; 124(3): 745-53, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18704681
13.
Are Patients with Active Cancer and Those with History of Cancer Carrying the Same Risks of Recurrent VTE and Bleeding While on Anticoagulants?
Cancers (Basel)
; 12(4)2020 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32283621
14.
Renal safety of gadolinium-based contrast media in patients with chronic renal insufficiency.
Radiology
; 250(3): 618-28, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19244037
15.
Long-term renal function in liver transplant recipients and impact of immunosuppressive regimens (calcineurin inhibitors alone or in combination with mycophenolate mofetil): the TRY study.
Liver Transpl
; 15(9): 1083-91, 2009 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-19718632
16.
[Non-iodinated contrast media nephrotoxicity]. / Toxicité rénale des produits de contraste non iodés.
Nephrol Ther
; 14(6): 484-490, 2018 Nov.
Artigo
em Francês
| MEDLINE | ID: mdl-30301611
17.
Pharmacokinetic/pharmacodynamic considerations for cancer patients undergoing hemodialysis.
Expert Opin Drug Metab Toxicol
; 13(6): 617-623, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28537215
18.
Course of chronic kidney disease in French patients.
Clin Kidney J
; 10(1): 74-78, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28638607
19.
[Renovascular effects of antiangiogenic drugs]. / Effets rénovasculaires des antiangiogéniques.
Bull Cancer
; 103(7-8): 662-6, 2016.
Artigo
em Francês
| MEDLINE | ID: mdl-27318610
20.
Renal insufficiency and cancer treatments.
ESMO Open
; 1(4): e000091, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27843635